USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus. Published in the Morbidity and Mortality Weekly Report on August 20, 1999.
Preface Categories Reflecting Strength and Quality of Evidence Disease Specific Recommendations Pneumocystis carinii Pneumonia Toxoplasmic Encephalitis Cryptosporidiosis Microsporidiosis Tuberculosis Disseminated Infection with Mycobacterium avium Complex Bacterial Respiratory Infections Bacterial Enteric Infections Infection with Bartonella (Formerly Rochalimaea) Candidiasis Cryptococcosis Histoplasmosis Coccidioidomycosis Cytomegalovirus Disease Herpes Simplex Virus Disease Varicella-Zoster Virus Infection Human Herpesvirus 8 Infection Human Papillomavirus Infection Hepatitis C Infection References
Table IA. Prophylaxis for First Episode Opportunistic Disease in HIV-Infected Adults and Adolescents Table IB. Prophylaxis for Recurrence of Opportunistic Disease in HIV-Infected Adults and Adolescents Table II. Clinically Relevant Drug-Food and Drug-Drug Interactions with Agents Used for the Prevention of Opportunistic Infections in HIV-Infected Patients Table. Drug Interactions Affecting Drugs Used to Prevent Opportunistic Infections Table. Effects of Opportunistic Infection Medication on Drugs Commonly Used in HIV-Infected Persons Table III. Adverse Effects of Drugs Used in the Managment of HIV Infection Table IV. Dosing of Drugs for Primary Prevention of Maintenance Therapy for Opportunistic Infections in Renal Insufficiency Table V. Wholesale Acquisition Costs of Agents Recommended for Prevention of Opportunistic Infections in Patients Who Have HIV Infection Table VI. Immunologic Categories for HIV-Infected Children Based on Age-Specific CD4+ T-Lymphocyte and Percentage of Total Lymphocytes* Table VIIA. Prophylaxis for First Episode of Opportunistic Disease in HIV-Infected Infants and Children Table VIIB. Prophylaxis for Recurrence of Opportunistic Disease (After Chemotherapy for Acute Disease) in HIV-Infected Infants and Children Table VIII. Advising Patients Concerning Prevention of Exposure to Opportunistic Pathogens Table IX. Criteria for Discontinuing and Restarting Opportunistic Infection Prophylaxis for Adult Patients with HIV Infection* Figure. Recommended Immunization Schedule for HIV-Infected Children*
Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.
html
pdf
selected tables
panel members
Preface